CCG
BRNS

Catalina Capital Group’s Barinthus Biotherapeutics BRNS Stock Holding History

Catalina Capital Group’s Portfolio BRNS Stock Details BRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,216
Closed -$12.3K – 210
2024
Q4 		$12.3K Sell
10,216
-10,296
-50% -$12.4K ﹤0.01% 365
2024
Q3 		$24.4K Buy
20,512
+2,693
+15% +$3.21K 0.01% 339
2024
Q2 		$24.9K Buy
+17,819
New +$24.9K 0.01% 308